Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Ankr Network Ankr Network +26.55%
#3 BankrCoin BankrCoin +15.90%
#4 Status Status +15.24%
#5 Siren Siren +8.82%
#6 WAX WAX +6.92%
#7 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +6.84%
#8 Wiki Cat Wiki Cat +6.64%
#9 would would +6.14%
#10 Asteroid Shiba Asteroid Shiba +5.16%
Coin of the day
Palladium Network Palladium Network
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Rang in Aktien #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Aktienkurs
$5.84
Zuletzt synchronisiert: 2025-04-02
Marktkapitalisierung
$224.09M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Nevro Corp. (NVRO)

Kategorie

Healthcare
P/S-Verhältnis für Nevro Corp. (NVRO)
P/S-Verhältnis zum September 2026 TTM: 0.55
Laut den neuesten Finanzberichten und dem Aktienkurs von Nevro Corp. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0.55. Am Ende des Jahres 2023 lag das P/S-Verhältnis bei 1.82.
P/S-Verlauf für Nevro Corp. von 2012 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
2026 (TTM) 0.55 61.32%
2024 0.34 -81.46%
2023 1.82 -47.08%
2022 3.44 -52.83%
2021 7.30 -54.68%
2020 16.10 73.55%
2019 9.28 207.44%
2018 3.02 -51.47%
2017 6.22 -31.35%
2016 9.06 -64.87%
2015 25.78 389.03%
2014 5.27 623.47%
2013 0.73 -22.76%
2012 0.94 0.00%
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.10 647.29%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
4.80 775.92%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 407.73%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.42 523.39%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.02 1,362.88%
US